Circulating immune mediators are closely linked in adult-onset type 1 diabetes as well as in non-diabetic subjects

References

• Kaas, A., C. Pfleger, L. Hansen, et al. 2010. Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis. Clin. Exp. Immunol. 161: 444–452
   PubMed Web of Science ®Google Scholar
• Pihoker, C., L. K. Gilliam, C. S. Hampe, and A. Lernmark. 2005. Autoantibodies in diabetes. Diabetes 54(Suppl 2): S52–S61
   Google Scholar
• Bending, D., P. Zaccone, and A. Cooke. 2012. Inflammation and type one diabetes. Int. Immunol. 24: 339–346
   PubMed Web of Science ®Google Scholar
• Rotondi, M., L. Chiovato, S. Romagnani, et al. 2007. Role of chemokines in endocrine autoimmune diseases. Endocr. Rev. 28: 492–520
   PubMed Web of Science ®Google Scholar
• King, G. L. 2008. The role of inflammatory cytokines in diabetes and its complications. J. Periodontol. 79: 1527–1534
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner, A., A. Sarandakou, J. Tziotis, et al. 1998. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr. Res. 44: 873–875
   PubMed Web of Science ®Google Scholar
• Pham, M. N., M. I. Hawa, C. Pfleger, et al. 2011. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: action LADA 4. Diabetologia 54: 1630–1638
   PubMed Web of Science ®Google Scholar
• Nicoletti, F., I. Conget, M. Di Mauro, et al. 2002. Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45: 1107–1110
   PubMed Web of Science ®Google Scholar
• Pfleger, C., H. B. Mortensen, L. Hansen, et al. 2008. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 57: 929–937
   PubMed Web of Science ®Google Scholar
• Schloot, N. C., P. Hanifi-Moghaddam, N. Aabenhus-Andersen, et al. 2007. Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission. Diabet. Med. 24: 512–520
   PubMed Web of Science ®Google Scholar
• Bastard, J. P., M. Maachi, C. Lagathu, et al. 2006. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17: 4–12
   PubMed Web of Science ®Google Scholar
• Shoelson, S. E., J. Lee, and A. B. Goldfine. 2006. Inflammation and insulin resistance. J. Clin. Invest. 116: 1793–1801
   PubMed Web of Science ®Google Scholar
• Fain, J. N. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74: 443–477
   PubMed Web of Science ®Google Scholar
• Radtke, M. A., I. Nermoen, M. Kollind, et al. 2010. Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control. Diabetes Care 33: 589–594
   PubMed Web of Science ®Google Scholar
• Kolb, H., K. Luckemeyer, T. Heise, et al. 2013. The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). PLoS One 8: e72440
   PubMed Web of Science ®Google Scholar
• Gabbay, M. A., M. N. Sato, A. J. Duarte, and S. A. Dib. 2012. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clin. Exp. Immunol. 168: 60–67
   PubMed Web of Science ®Google Scholar
• Donath, M. Y., and S. E. Shoelson. 2011. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11: 98–107
   PubMed Web of Science ®Google Scholar
• Nokoff, N. J., M. Rewers, and M. Cree Green. 2012. The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov. Med. 13: 115–122
   PubMed Web of Science ®Google Scholar
• Wilkin, T. J. 2012. The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis. Pediatr. Diabetes 13: 334–339
   PubMed Web of Science ®Google Scholar
• Schulte, B. M., K. H. Lanke, J. D. Piganelli, et al. 2012. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes 61: 2030–2036
   PubMed Web of Science ®Google Scholar
• Alvarez-Rodriguez, L., M. Lopez-Hoyos, P. Munoz-Cacho, and V. M. Martinez-Taboada. 2012. Aging is associated with circulating cytokine dysregulation. Cell. Immunol. 273: 124–132
   PubMed Web of Science ®Google Scholar